Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Venetoclax-azacitidine in combination with chidamide and CAG versus daunorubicin and cytarabine in newly diagnosed AML

Lei Lv, Sai Huang, Qingyang Liu, Daihong Liu, Liping Dou

Blood (2025) 146 (Supplement 1): 3416.

https://doi.org/10.1182/blood-2025-3416

Published: 2025

Journal Articles

Ruxolitinib combined with decitabine-intensified modified busulfan/cyclophosphamide conditioning regimen reduces relapse after allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia

Daihong Liu, Liping Dou, Weiqi Li

Blood (2025) 146 (Supplement 1): 5969.

https://doi.org/10.1182/blood-2025-5969

Published: 2025

Journal Articles

Does intensive consolidation confer a clinical advantage over continued less intensive therapy in elderly patients with Acute Myeloid Leukemia in first remission following azacitidine plus venetoclax induction?

Blood (2025) 146 (Supplement 1): 5162.

https://doi.org/10.1182/blood-2025-5162

Published: 2025

Journal Articles

Comparative clinical outcomes of offspring versus matched sibling donor hematopoietic stem cell transplantation in adults aged over 40 years with acute leukemia or Myelodysplastic Syndromes

Yujun Wei, Jingwen Tang, Liping Dou, Daihong Liu

Blood (2025) 146 (Supplement 1): 7796.

https://doi.org/10.1182/blood-2025-7796

Published: 2025

Journal Articles

HOXA9/METTL3/BMI1 axis is required for promoting anthracycline resistance in acute myeloid leukemia cells by modulating BMI1 expression through mRNA m6A modification

Hao Wang, Daihong Liu, Liping Dou

Blood (2025) 146 (Supplement 1): 5246.

https://doi.org/10.1182/blood-2025-5246

Published: 2025

Journal Articles

Pharmacokinetics-guided ATG targeted dosing strategy in unmanipulated haploidentical haematopoietic stem cell transplantation: A randomized, multicenter, phase 3 clinical trial

Daihong Liu, Liping Dou, haoyang zhang

Blood (2025) 146 (Supplement 1): 2447.

https://doi.org/10.1182/blood-2025-2447

Published: 2025

Journal Articles

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

Blood (2025) 146 (Supplement 1): 120.

https://doi.org/10.1182/blood-2025-120

Published: 2025

Journal Articles

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Blood (2025) 146 (Supplement 1): 4267.

https://doi.org/10.1182/blood-2025-4267

Published: 2025

Journal Articles

Maribavir for cytomegalovirus infections after hematopoietic stem cell transplantation: A real world comparative cohort study

jiaxin cao, Lu Wang, Aiming Pang, Liping Dou, Erlie Jiang

Blood (2025) 146 (Supplement 1): 4264.

https://doi.org/10.1182/blood-2025-4264

Published: 2025

Journal Articles

Synergistic effect of HLA evolutionary divergence and post-transplant biomarkers on non-relapse mortality prediction in adult haploidentical hematopoietic stem cell transplantation

Liping Dou, Di Guan, Yang-Liu Shao, Xiaobo Li, Ziqi Wang, Jingbo Wang, Yimei Feng, Xi Zhang, Xiangjun Liu, Daihong Liu

Blood (2025) 146 (Supplement 1): 2474.

https://doi.org/10.1182/blood-2025-2474

Published: 2025

Journal Articles

Iguratimod plus low-dose rituximab as second-line treatment in adults with primary immune thrombocytopenia: A multicenter, open-label, randomized, controlled, Phase 2 trial

Qiu-Sha Huang, Zhuo-Yu An, Peng Zhao, Qi Chen, Jin Wu, Hai-Xia Fu, Yujun Dong, Hongmei Jing, Liping Dou, Hui Liu, Yi Liu, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3044.

https://doi.org/10.1182/blood-2025-3044

Published: 2025

Journal Articles

Venetoclax combined with cacag regimen as a bridge to allogeneic hematopoietic stem cell transplantation in patients with previously untreated acute myeloid leukemia achieving CR1

Daihong Liu, Liping Dou, Yu Fang

Blood (2025) 146 (Supplement 1): 6951.

https://doi.org/10.1182/blood-2025-6951

Published: 2025

Journal Articles

Venetoclax-azacitidine-chidamide plus CAG (CACAG-VEN) versus “3+7” induction chemotherapy in Intermediate-adverse Acute Myeloid Leukemia: Efficacy and safety

Lei Lv, Jingjing Yang, Liping Dou

Blood (2025) 146 (Supplement 1): 5236.

https://doi.org/10.1182/blood-2025-5236

Published: 2025

Journal Articles

Linperlisib Combined with CHOP Regimen Followed By Autologous Hematopoietic Stem Cell Transplantation and Linperlisib Monotherapy Maintenance for Newly Diagnosed Nodal T-Follicular Helper Cell Lymphoma Patients: A Phase II Trial

Weiping Liu, Yao Liu, Zengjun Li, Shujuan Wen, Zhihua Zhang, Liqun Zou, Ming Jiang, Liping Dou, Ou Bai, Jie Yu, Yue Wang, Jie Chen, Yuqin Song, Jun Zhu

Blood (2024) 144 (Supplement 1): 6389.

https://doi.org/10.1182/blood-2024-199929

Published: 2024

Journal Articles

A Pragmatic Monitoring Model for Non-Relapse Mortality Risk Based on Machine Learning in Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation

Yang-Liu Shao, Jingjing Yang, Xiaobo Li, Di Guan, Xiawei Zhang, Wu Tong, Zeliang Song, Dao Wang, Zhijie Wei, Jingbo Wang, Xiangjun Liu, Yuelin He, Liping Dou, Daihong Liu

Blood (2024) 144 (Supplement 1): 3573.

https://doi.org/10.1182/blood-2024-203190

Published: 2024

Journal Articles

CMV-Specific TCR-T Cells for the Treatment of CMV Reactivation after Allogeneic Hematopoietic Stem-Cell Transplantation

Jingwen Tang, Liping Dou, Daihong Liu

Blood (2024) 144 (Supplement 1): 3462.

https://doi.org/10.1182/blood-2024-204804

Published: 2024

Journal Articles

Lymphocyte Dynamics during the Treatment of SR-aGVHD with Mesenchymal Stem Cells Derived from Human Umbilical Cord Blood - a Phase III, Multi-Center, Prospective, Single-Arm Pivotal Study

Sheng Chen, Dongxue Ge, Kun Qian, Jingwen Tang, Yujun Wei, Liping Dou, Daihong Liu

Blood (2024) 144 (Supplement 1): 2135.

https://doi.org/10.1182/blood-2024-204735

Published: 2024

Journal Articles

Phase Ⅱ Study of Chidamide in Combination with Dcag and Venetoclax for Refractory/Relapsed Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis

Qingyang Liu, Yanan Wen, Xiawei Zhang, Wenjing Gao, Daihong Liu, Liping Dou

Blood (2024) 144 (Supplement 1): 6070.

https://doi.org/10.1182/blood-2024-204739

Published: 2024

Journal Articles

A Phase I Study of Chidamide in Combination with Dcag and Venetoclax in Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis

Xiawei Zhang, Jingjing Yang, Sai Huang, Qingyang Liu, Liping Dou, Chunji Gao, Daihong Liu

Blood (2024) 144 (Supplement 1): 1519.

https://doi.org/10.1182/blood-2024-204782

Published: 2024

Journal Articles

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Blood (2023) 142 (Supplement 1): 1207.

https://doi.org/10.1182/blood-2023-181622

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Venetoclax-azacitidine in combination with chidamide and CAG versus daunorubicin and cytarabine in newly diagnosed AML

Ruxolitinib combined with decitabine-intensified modified busulfan/cyclophosphamide conditioning regimen reduces relapse after allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia

Does intensive consolidation confer a clinical advantage over continued less intensive therapy in elderly patients with Acute Myeloid Leukemia in first remission following azacitidine plus venetoclax induction?

Comparative clinical outcomes of offspring versus matched sibling donor hematopoietic stem cell transplantation in adults aged over 40 years with acute leukemia or Myelodysplastic Syndromes

HOXA9/METTL3/BMI1 axis is required for promoting anthracycline resistance in acute myeloid leukemia cells by modulating BMI1 expression through mRNA m6A modification

Pharmacokinetics-guided ATG targeted dosing strategy in unmanipulated haploidentical haematopoietic stem cell transplantation: A randomized, multicenter, phase 3 clinical trial

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Maribavir for cytomegalovirus infections after hematopoietic stem cell transplantation: A real world comparative cohort study

Synergistic effect of HLA evolutionary divergence and post-transplant biomarkers on non-relapse mortality prediction in adult haploidentical hematopoietic stem cell transplantation

Iguratimod plus low-dose rituximab as second-line treatment in adults with primary immune thrombocytopenia: A multicenter, open-label, randomized, controlled, Phase 2 trial

Venetoclax combined with cacag regimen as a bridge to allogeneic hematopoietic stem cell transplantation in patients with previously untreated acute myeloid leukemia achieving CR1

Venetoclax-azacitidine-chidamide plus CAG (CACAG-VEN) versus “3+7” induction chemotherapy in Intermediate-adverse Acute Myeloid Leukemia: Efficacy and safety

Linperlisib Combined with CHOP Regimen Followed By Autologous Hematopoietic Stem Cell Transplantation and Linperlisib Monotherapy Maintenance for Newly Diagnosed Nodal T-Follicular Helper Cell Lymphoma Patients: A Phase II Trial

A Pragmatic Monitoring Model for Non-Relapse Mortality Risk Based on Machine Learning in Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation

CMV-Specific TCR-T Cells for the Treatment of CMV Reactivation after Allogeneic Hematopoietic Stem-Cell Transplantation

Lymphocyte Dynamics during the Treatment of SR-aGVHD with Mesenchymal Stem Cells Derived from Human Umbilical Cord Blood - a Phase III, Multi-Center, Prospective, Single-Arm Pivotal Study

Phase Ⅱ Study of Chidamide in Combination with Dcag and Venetoclax for Refractory/Relapsed Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis

A Phase I Study of Chidamide in Combination with Dcag and Venetoclax in Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only